Fisioterapia : Impact Factor & More
eISSN: 1578-2107pISSN: 0211-5638
Share this on:
Key Metrics
CiteScore 
0.3
SNIP
0.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Fisioterapia Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Editorial Garsi |
Planning to publish in Fisioterapia ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Fisioterapia
Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8 + T cells
- 31 Dec 2026
- OncoImmunology
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanoma
- 31 Dec 2026
- OncoImmunology
Pharmacological inhibition of MAPK P38α rescues the immune defect of dendritic cells affected by the FPR1 loss-of-function polymorphism rs867228
- 31 Dec 2026
- OncoImmunology
Telomere damage enhances immunogenicity of neuroblastoma and accelerates response to anti-PD-L1 treatment
- 31 Dec 2026
- OncoImmunology
Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation
- 31 Dec 2026
- OncoImmunology
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models
- 31 Dec 2026
- OncoImmunology
Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8 + T cells
- 31 Dec 2026
- OncoImmunology
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanoma
- 31 Dec 2026
- OncoImmunology
Pharmacological inhibition of MAPK P38α rescues the immune defect of dendritic cells affected by the FPR1 loss-of-function polymorphism rs867228
- 31 Dec 2026
- OncoImmunology
Telomere damage enhances immunogenicity of neuroblastoma and accelerates response to anti-PD-L1 treatment
- 31 Dec 2026
- OncoImmunology
Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation
- 31 Dec 2026
- OncoImmunology
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models
- 31 Dec 2026
- OncoImmunology
FAQs on Fisioterapia
How many articles did Fisioterapia publish last year? 
What is the eISSN & pISSN for Fisioterapia?
What is Citescore for Fisioterapia?
What is SNIP score for Fisioterapia?
Who is the publisher of Fisioterapia?
